BDPT Stock Overview
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioAdaptives, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0014 |
| 52 Week Low | US$0.0002 |
| Beta | 0.35 |
| 11 Month Change | -80.95% |
| 3 Month Change | -66.67% |
| 1 Year Change | -80.00% |
| 33 Year Change | -98.99% |
| 5 Year Change | -99.80% |
| Change since IPO | -99.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDPT | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -20.0% | -1.6% | -2.1% |
| 1Y | -80.0% | -13.8% | 29.7% |
Return vs Industry: BDPT underperformed the US Personal Products industry which returned -14.2% over the past year.
Return vs Market: BDPT underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| BDPT volatility | |
|---|---|
| BDPT Average Weekly Movement | 45.6% |
| Personal Products Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BDPT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BDPT's weekly volatility has increased from 35% to 46% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 4 | James Keener | www.shopbioadaptives.com |
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, improves wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow.
BioAdaptives, Inc. Fundamentals Summary
| BDPT fundamental statistics | |
|---|---|
| Market cap | US$246.35k |
| Earnings (TTM) | -US$771.09k |
| Revenue (TTM) | US$35.52k |
6.9x
P/S Ratio-0.3x
P/E RatioIs BDPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDPT income statement (TTM) | |
|---|---|
| Revenue | US$35.52k |
| Cost of Revenue | US$45.49k |
| Gross Profit | -US$9.97k |
| Other Expenses | US$761.12k |
| Earnings | -US$771.09k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00063 |
| Gross Margin | -28.07% |
| Net Profit Margin | -2,170.91% |
| Debt/Equity Ratio | -18.2% |
How did BDPT perform over the long term?
See historical performance and comparison